Kazuhisa Ishida
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Kazuhisa Ishida has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Itaru Nishida
Department of Neuropathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan 1
1 shared publication - Kaoru Yamada
Department of Neuropathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
1 shared publication - Masato Yasui
Department of Pharmacology, KEIO University School of Medicine, Tokyo 160-8582, Japan
1 shared publication - Risa Nishiyama
Department of Neuropathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan 1
1 shared publication - Tadafumi Hashimoto
Department of Neuropathology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan
1 shared publication - Takeshi Iwatsubo
Department of Neuropathology, Graduate School of Medicine, The University of Tokyo
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 25 February 2022
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 219 (3)
Glymphatic system clears extracellular tau and protects from tau aggregation and neurodegeneration
Accumulation of tau has been implicated in various neurodegenerative diseases termed tauopathies. Tau is a microtubule-associated protein but is also actively released into the extracellular fluids including brain interstitial fluid and cerebrospinal fluid (CSF). However, it remains elusive whether clearance of extracellular tau impacts tau-associated neurodegeneration. Here, we show that aquaporin-4 (AQP4), a major driver of the glymphatic clearance system, facilitates the elimination of extracellular tau from the brain to CSF and subsequently to deep cervical lymph nodes. Strikingly, deletion of AQP4 not only elevated tau in CSF but also markedly exacerbated phosphorylated tau deposition and the associated neurodegeneration in the brains of transgenic mice expressing P301S mutant tau. The current study identified the clearance pathway of extracellular tau in the central nervous system, suggesting that glymphatic clearance of extracellular tau is a novel regulatory mechanism whose impairment contributes to tau aggregation and neurodegeneration.
- 25 February 2022
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 219 (3)
Top Cited PapersOpen AccessGlymphatic system clears extracellular tau and protects from tau aggregation and neurodegeneration
Accumulation of tau has been implicated in various neurodegenerative diseases termed tauopathies. Tau is a microtubule-associated protein but is also actively released into the extracellular fluids including brain interstitial fluid and cerebrospinal fluid (CSF). However, it remains elusive whether clearance of extracellular tau impacts tau-associated neurodegeneration. Here, we show that aquaporin-4 (AQP4), a major driver of the glymphatic clearance system, facilitates the elimination of extracellular tau from the brain to CSF and subsequently to deep cervical lymph nodes. Strikingly, deletion of AQP4 not only elevated tau in CSF but also markedly exacerbated phosphorylated tau deposition and the associated neurodegeneration in the brains of transgenic mice expressing P301S mutant tau. The current study identified the clearance pathway of extracellular tau in the central nervous system, suggesting that glymphatic clearance of extracellular tau is a novel regulatory mechanism whose impairment contributes to tau aggregation and neurodegeneration.